HS-IT201 injection for advanced solid tumors
Part of Cancer clinical trials.
This trial tests an investigational cell therapy called HS-IT201 for people with advanced solid tumors that have not responded to standard treatments. It aims to see if this treatment can help shrink tumors or slow their growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You have an advanced solid tumor (like kidney, lung, stomach, colorectal, or melanoma) that has not responded to or cannot tolerate standard treatments.
- You have at least one tumor that can be removed surgically and weighs at least 0.05 grams.
- You have at least one other tumor that can be measured on scans that has not had recent radiation or local therapy.
- You are in relatively good health otherwise, with a performance status of 0 or 1 (able to carry out daily activities).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental cell therapy (HS-IT101) for people with advanced solid tumors that have not responded to standard treatments. It uses immune cells from your own tumor to fight cancer, and researchers want to see if it is safe and effective.
This Phase 1 study tests HS-20117 to see if it is safe and how well it works in people with advanced solid tumors. You may qualify if your cancer has progressed after standard treatments (or you can’t tolerate them) and you can provide new or stored tumor tissue for testing.
This trial tests an investigational medicine called HS-20117-2 for people with advanced solid tumors that haven't responded to other treatments. The goal is to see if it is safe and if it might help shrink or control the tumor.
This trial tests a new drug called HS-20105 for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called HS-20122 in people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and effective.
This early-phase trial tests whether collecting immune cells from your tumor (tumor infiltrating lymphocytes) is safe and can help treat advanced solid cancers. It may help by strengthening your body’s immune attack on the cancer after standard treatments are no longer working.
Hear when a new Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.